Affitech A/S

Eli Lilly & Co. 's chief financial officer (CFO) Derica Rice will be retiring at the end of this year after being at the company for 27 years. Rice was previously Lilly's executive vice president

Hopes for what would have been the first therapeutic vaccine for pancreatic cancer have been dashed by the Phase III failure of KAEL-GemVax's GV1001, forcing the South Korean firm to reconsider the fu

A telomerase peptide oncovaccine being developed by the South Korean group KAEL-GemVax and already in a major Phase III programme for pancreatic cancer has also shown clinical promise in the treatment

Being part of a large listed group relieves KAEL-GemVax from the constant fundraising headaches typical of its peers, writes Ian Haydock. This article is part of the 2011 Scrip Asia 100 . With a p